External Review: When and How to Escalate Beyond the Payer

When a practice has exhausted a payer's internal appeal process and the denial stands, many assume the fight is over. It is not. External review — an independent evaluation of the denial by a third party outside the insurance company — exists as a critical safeguard against inappropriate denials. Yet it remains one of the most underused tools in denial management.

According to KFF, external appeals in Marketplace plans result in overturns roughly 40% of the time — a rate that suggests many denials upheld through internal appeals cannot withstand independent scrutiny. For physician practices, understanding when and how to escalate to external review can mean the difference between a written-off denial and a recovered claim.

What External Review Is

External review is a process mandated by both federal and state law in which an Independent Review Organization (IRO) — a third party with no financial relationship to the payer — reviews the denial and makes a binding determination. The Affordable Care Act (ACA) established minimum external review standards for non-grandfathered health plans, and most states have their own external review laws that may provide additional protections.

The key distinction is independence. During internal appeals, the payer is reviewing its own decision. During external review, an independent physician or clinical panel evaluates whether the denial was appropriate based on the clinical evidence and applicable standards of care. The IRO reviewer typically has no prior involvement with the case and no incentive to uphold or overturn the denial.

For Medicare Advantage plans, the equivalent process involves the Independent Review Entity (IRE), currently operated by Maximus Federal Services under contract with CMS. The IRE reviews MA plan reconsideration decisions that are unfavorable to the enrollee. Beyond the IRE, further appeals can proceed to an Administrative Law Judge.

When External Review Is Available

External review is available in specific circumstances, and understanding the eligibility criteria is essential:

• After internal appeals are exhausted. In most cases, you must complete the payer's internal appeal process before requesting external review. Skipping the internal process typically makes the case ineligible for external review.
• Medical necessity denials. External review is most commonly available for denials based on medical necessity, including determinations that a treatment is experimental or investigational. It is generally not available for denials based on eligibility, contractual exclusions, or benefit design (e.g., a service that is simply not covered under the plan).
• Expedited external review. For urgent situations — where waiting for the standard external review timeline could seriously jeopardize the patient's life or health — expedited external review is available, often with a 72-hour decision timeline. This is critical for time-sensitive treatments such as cancer therapy or urgent surgical procedures.
• Within filing deadlines. External review requests must be filed within specific timeframes after the final internal appeal decision. Under federal standards, the minimum filing window is four months, but state laws may provide shorter or longer periods. Missing the deadline forfeits the right to external review.

When to Escalate: A Decision Framework

Not every denied claim warrants escalation to external review. The process requires time and effort, and the decision to escalate should be informed by several factors:

1. Strength of the clinical case. External review is most likely to succeed when the clinical evidence clearly supports the denied service. If the patient meets published clinical guidelines for the treatment — and especially if the payer's own medical policy criteria are met — external review is strongly indicated. If the clinical case is ambiguous, success is less predictable.
2. Financial materiality. The dollar value of the denied claim matters. For a $200 lab test, the staff time required to prepare an external review filing may exceed the potential recovery. For a $15,000 surgical procedure or a $50,000 biologic medication course, the math is different. Practices should establish dollar-value thresholds that trigger external review consideration.
3. Pattern identification. If a payer is systematically denying a particular service that your practice provides — and internal appeals consistently fail — external review can serve a strategic purpose beyond the individual claim. An external review overturn creates a precedent that can be referenced in future appeals and contract discussions with that payer.
4. Patient impact. When the denied service is clinically urgent and the patient is waiting for treatment, escalating to expedited external review may be the fastest path to authorization. The 72-hour expedited review timeline is faster than many standard internal appeal timelines.

Preparing a Strong External Review Submission

The external review submission is your practice's opportunity to present the strongest possible case to an independent reviewer. The quality of the submission directly affects the outcome. Key elements include:

• A clear clinical narrative. The reviewer may not be familiar with the patient's full history. A concise but thorough narrative that explains the patient's condition, treatment history, and clinical rationale for the requested service provides essential context.
• Specific clinical evidence. Include relevant lab results, imaging reports, pathology reports, and clinical assessment scores. The evidence should directly address the criteria the payer cited in its denial.
• Guideline citations. Reference the specific clinical practice guidelines that support the requested treatment, including the publishing organization, guideline title, year, and relevant recommendation. If the treatment is supported by peer-reviewed research beyond the guidelines, include those citations as well.
• The payer's stated reason for denial. Include the denial letter and specifically address each reason the payer cited. If the payer's criteria are more restrictive than published guidelines, note this explicitly.
• A physician attestation. A statement from the treating physician explaining, in clinical terms, why the denied treatment is medically necessary for this specific patient carries significant weight with independent reviewers.

The Broader Strategic Value

External review serves a purpose beyond individual claim recovery. When a practice consistently escalates inappropriate denials to external review — and consistently wins — it sends a signal to the payer. Payers track their external review overturn rates, and a pattern of overturns for a specific provider or a specific service can prompt internal review of the denial criteria that led to those overturns.

Additionally, external review outcomes can inform regulatory complaints. When an IRO overturns a denial, it is an independent finding that the payer's decision was not supported by the clinical evidence. This finding can be cited in complaints to state insurance departments, in responses to payer contract negotiations, and in any regulatory proceedings related to payer conduct.

Do Not Leave This Tool on the Shelf

The data consistently shows that external review is underutilized relative to its success rate. Practices that write off denials after failed internal appeals are accepting a payer's self-interested determination as final when an independent check is available. The process is not burdensome when the clinical case is strong and the submission is well-prepared. For high-value denials with solid clinical support, external review should be a standard part of the denial management playbook — not an afterthought.